[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.113.179. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 9, 1988

Evaluation of the WHO Clinical Case Definition for AIDS in Uganda

Author Affiliations

From the AIDS Control Programme, Ministry of Health and World Health Organization (Drs Widy-Wirski, Downing, Okware, and Lwegaba), the Epidemiology Unit, Ministry of Health, and the Uganda Project of the Task Force for Child Survival (Dr Berkley), and Uganda Virus Research Institute (Dr Sempala), Entebbe, Uganda; the Department of Internal Medicine, Mulago Hospital, Kampala, Uganda (Dr Mugerwa); and Directorate General of Cooperation for Development, Ministry of Foreign Affairs, Rome (Dr Recine).

From the AIDS Control Programme, Ministry of Health and World Health Organization (Drs Widy-Wirski, Downing, Okware, and Lwegaba), the Epidemiology Unit, Ministry of Health, and the Uganda Project of the Task Force for Child Survival (Dr Berkley), and Uganda Virus Research Institute (Dr Sempala), Entebbe, Uganda; the Department of Internal Medicine, Mulago Hospital, Kampala, Uganda (Dr Mugerwa); and Directorate General of Cooperation for Development, Ministry of Foreign Affairs, Rome (Dr Recine).

JAMA. 1988;260(22):3286-3289. doi:10.1001/jama.1988.03410220070030
Abstract

Infections with human immunodeficiency virus are common in areas of the world where laboratory testing and sophisticated diagnostic facilities are unavailable. A World Health Organization clinical case definition for acquired immunodeficiency syndrome was developed in 1985 for use in such areas. In 1987, we tested this definition on 1328 inpatients and outpatients in 15 hospitals throughout Uganda. Five hundred sixty-two patients (42%) were positive by enzyme-linked immunosorbent assay for human immunodeficiency virus antibody. The World Health Organization definition had a sensitivity of 55%, a specificity of 85%, and a positive predictive value of 73%. Modification of the case definition by excluding a known cough from tuberculosis as a minor criteria decreased sensitivity slightly to 52%, but specificity and positive predictive value increased to 92% and 83%, respectively. Amenorrhea, although not specifically asked about, was a symptom noted by many female patients (26% of females who were positive by enzyme-linked immunosorbent assay); as a symptom indicative of human immunodeficiency virus infection, amenorrhea had a specificity of 99%, with a positive predictive value of 89%. These findings support the generalizability of the World Health Organization clinical acquired immunodeficiency syndrome definition and its use (especially the modified version) in areas of Uganda without sophisticated facilities.

(JAMA 1988;260:3286-3289)

×